TAO Synergies Inc. SEC filings TAOX

TAO Synergies Inc. has 243 filings in SEC EDGAR's recent list, going back to Mar 13, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Dec 19, 2025 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.

TAO Synergies Inc. SEC filings
Form Description Filed Period
10-K/A Amended annual report Jun 5, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2026 Dec 31, 2025
ARS Annual report to shareholders Nov 17, 2025 Dec 31, 2024
10-K Annual report Mar 27, 2025 Dec 31, 2024
ARS Annual report to shareholders Nov 5, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
ARS Annual report to shareholders Nov 14, 2023 Dec 31, 2022
10-K Annual report Mar 21, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2022 Dec 31, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Finance Services (SIC 6199)
Listed as
TAOX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1571934
Former names
Synaptogenix, Inc. (until Jun 24, 2025); NEUROTROPE BIOSCIENCE, INC. (until Nov 20, 2020)

Other Finance Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.